Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

Scient’x Announces Strategic Alliance In Dynamic Fusion with Allegheny General Hospital BY EDITOR, OCTOBER 1, 2009

GUYANCOURT, France & PITTSBURGH--(BUSINESS WIRE)--Scient’x Group S.A.S. (Scient’x), the worldwide leader in providing dynamic solutions for both fusion and non-fusion* procedures for the spine, today announced a strategic alliance with Allegheny General Hospital (AGH) in Pittsburgh, PA that will include collaborative biomechanical and clinical research, technology development and medical education.

AGH is a nationally-recognized academic medical center that serves as the flagship hospital of the West Penn Allegheny Health System and a campus of the Drexel University School of Medicine. The hospital is designated as both a Neurosciences Center of Excellence and a Spine Center of Excellence, based on a recent independent study of neurosurgical capabilities and patient care quality at medical centers around the country. AGH is home to one of the nation’s largest and most comprehensive neurosurgical programs and has a longstanding history of pioneering research in the neurosciences field.

Scient’x recently launched its new strategy focusing on dynamic fusion, including the introduction of its Isobar Evolution Dynamic Rod, which is indicated as an adjunct to fusion for the lumbar spine.

Oliver Burckhardt, President and CEO of Scient’x, said: “Partnering with an institution like AGH will expedite the study and global acceptance of such innovative technologies.

“Scient’x is honored and privileged to collaborate with a preeminent medical center in the United States as we embark upon the next phase of our research and development. This alliance with AGH not only greatly enhances our R&D capabilities, but it brings a vital academic influence to our new dynamic strategy. We are excited to have such an exceptional group of surgeons and researchers join our efforts to forge an outcomes-based path in this emerging dynamic fusion sector,” Mr. Burckhardt added.

Jack Wilberger, MD, Chairman of the Department of Neurosurgery at both AGH and Drexel University College of Medicine, commented: “Advancing the state-of-the-art and exploring new frontiers in the treatment of neurological disease has been a hallmark of our program for the past half century. We are extremely proud of these accomplishments because the work has truly helped improve the lives of many people. This new affiliation with Scient’x further strengthens our ability to continue that tradition.”

According to Donald Whiting, MD, Vice-Chair of Research in AGH’s Department of Neurosurgery and Clinical Co-Director of the hospital’s Neurosurgery, Spine & Biomechanics Research Laboratory, the recent opening of AGH’s Neurosciences Institute and expansion of its research capabilities “has helped open the door to collaborations with biomedical industry leaders like Scient’x.”

The Neurosurgery Spine and Biomechanics Research Laboratory is located within the Allegheny Singer Research Institute (ASRI), the research arm of AGH.

”Our affiliation with Scient’x is exciting on many levels. As the principal investigation site of an impending clinical trial exploring the efficacy of dynamic lumbar fusion, we at AGH are taking the lead on an important study that will better define the concept and science of dynamic fusion as it is applied now in the lumbar spine,” Dr. Whiting added.

Boyle Cheng, PhD, Director of AGH’s Neurosurgery, Spine & Biomechanics Research Laboratory and a nationally-recognized expert in degenerative spine disease, said: “The hospital is well-positioned to lead innovative, translational research projects such as those sponsored by Scient’x.

“Our impressive research facilities, combined with the unique, close collaboration that exists among our clinicians and scientists, affords us the opportunity to play a critical role in potentially groundbreaking studies that move quickly from the laboratory to the bedside. The partnership with Scient’x is a terrific example of that opportunity and we look forward to working with them in the pursuit of more effective treatments for degenerative spine disease,” Dr. Cheng added.

*Non-Fusion technologies not available in the United States.

Email this to a colleague: